Showing results (621-630 of 633) with videos related to
Sort By:
Pageof 64
Metabolic Brain Disease|August 5, 2016
A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopyVijay P B Grover, Mark J W McPhail, Marzena Wylezinska-Arridge, et al.Clinical and Experimental Gastroenterology|April 1, 2021
The Role of National Specialist Societies in Influencing Transformational Change in Low-Middle Income Countries - Reflections on the Model of Implementation for a National Endoscopy Training Programme in BangladeshNeil Hawkes, Umakant Dave, Mesbah Rahman, et al.Alimentary Pharmacology & Therapeutics|September 9, 2016
Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imagingV P B Grover, L Southern, J K Dyson, et al.Hepatology (Baltimore, Md.)|June 7, 2017
Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trialJasmohan S Bajaj, Zain Kassam, Andrew Fagan, et al.Gut Microbes|May 16, 2023
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitisLaura Martinez-Gili, Alexandros Pechlivanis, Julie A K McDonald, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 4, 2018
Alterations in gut microbial function following liver transplantJasmohan S Bajaj, Genta Kakiyama, I Jane Cox, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 21, 2017
Rifaximin in non-alcoholic steatohepatitis: An open-label pilot studyJeremy F L Cobbold, Stephen Atkinson, Julian R Marchesi, et al.Scientific Reports|October 29, 2021
Mapping of population disparities in the cholangiocarcinoma urinary metabolomeMunirah Alsaleh, Zoe Leftley, Thomas O'Connor, et al.Journal of Clinical and Experimental Hepatology|February 7, 2020
Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom CohortMunirah Alsaleh, Zoe Leftley, Thomas A Barbera, et al.The Lancet. Global Health|July 23, 2016
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) studyMaud Lemoine, Yusuke Shimakawa, Ramou Njie, et al.Pageof 64